Abstract Alterations in early life nutrition lead to an increased risk of obesity and metabolic syndrome in offspring. We have shown that both relative maternal undernutrition (UN) and maternal obesity result in metabolic derangements in offspring, independent of the postnatal dietary environment. Since insulin-like growth factor binding protein 2 (IGFBP2) has been shown to be independently associated with obesity and diabetes risk, we examined the IGF-IGFBP axis in male rat offspring following either maternal UN or maternal obesity to explain possible common pathways in the development of metabolic disorders. Wistar rats were time-mated and fed either a control diet (CONT), 50 % of CONT (UN) or a high-fat (HF) diet throughout pregnancy. Male offspring were weaned onto a standard chow diet and blood and tissues were collected at postnatal day 160. Plasma and hepatic tissue samples were analysed for key players in the IGF-IGFBP system. Both maternal UN and HF resulted in increased fat mass, hyperinsulinemia, hyperleptinemia and altered blood lipid profiles in offspring compared to CONT. Circulating IGF-1 and IGFBP3 levels and hepatic mRNA expression of IGFBP1 and IGFBP2 were significantly decreased in UN and HF offspring compared to CONT. DNA methylation of the IGFBP2 promotor region was similar between maternal dietary groups. Although chaperone gene heat-shock protein 90 and hepatic IGFBP1 were significantly correlated in CONT offspring this effect was absent in both UN and HF offspring. In conclusion, this study is one of the first to directly compare two experimental models of developmental programming representing both ends of the maternal dietary spectrum. Our data suggest that two disparate nutritional models that elicit similar adverse metabolic phenotypes in offspring are characterised by common alterations in the IGF-IGFBP pathway.
Introduction
It is well established that alterations in early life nutrition have lifelong consequences for the health and wellbeing of the individual. Clinical and animal studies have shown that both maternal undernutrition (UN) and maternal obesity lead to an increased risk of obesity and related metabolic disorders in offspring [1] [2] [3] [4] . Despite the similarity in offspring phenotypes elicited by both maternal obesity and UN, there has been limited direct investigation of these models in parallel as regards mechanisms underpinning the observed metabolic dysfunction. In particular, despite marked catchup growth in both experimental models, little is known about the growth hormone (GH)-insulin-like growth factor (IGF) system in the setting of developmental programming.
The IGF system is integral to normal growth and development; IGF-2 is known to regulate foetal and early infant growth, and IGF-1 plays a dominant role in growth throughout childhood. Bioavailability of IGF-1 is predominantly determined by binding to six IGF binding proteins (IGFBPs 1-6), although recent evidence indicates that IGFBPs also have direct IGF-independent metabolic effects [5] . For example, IGFBP3 has been shown to be involved in regulation of adipogenesis [6] , while IGFBP2 is independently associated with obesity and diabetes risk in adults [7, 8] and children [9] .
IGFBP2 is the second most abundant plasma circulating IGFBP, but its physiological role remains poorly understood. Overall, there appears to be an inverse association between IGFBP2 and adiposity-related insulin resistance, but much is still unknown about the exact nature of this relationship [10] . Mice overexpressing IGFBP2 are protected from high-fat-diet-induced obesity and glucose intolerance and display increased insulin sensitivity [11] . Moreover, hyperinsulinemic clamp studies showed a threefold improvement in hepatic insulin sensitivity following IGFBP2 treatment of ob/ob mice [12] . In clinical studies, circulating IGFBP2 in adulthood has been shown to be inversely associated with current adiposity [13] and it has been proposed as a strong marker for the metabolic syndrome in humans [8, 14, 15] . As IGFBP2 is the major IGFBP expressed in early life, and is also the predominant adipocyte-derived IGFBP, it is ideally positioned to act as a keystone between nutrition, growth and metabolism [16] . In addition to IGFBP2, low plasma levels of IGF-1, particularly when coupled with low levels of the potentially inhibitory IGF binding protein (IGFBP)-1, have been implicated in the pathogenesis of metabolic syndrome and cardiovascular disease [17] .
Little is known about alterations in IGF-IGFBP regulation in adult offspring following early life nutritional compromise; previous studies have focussed on the immediate foetal and neonatal period following the nutritional intervention. Foetal cord blood concentrations of glucose, insulin, IGF-1, and IGF-2 are significantly reduced in pregnancies complicated by intrauterine growth restriction (IUGR) [18] . In placentas from males from preterm deliveries, there is an overexpression of both IGF-2 and IGFBP3 genes [19] . Further, in placentas from pregnancies with IUGR, IGF-2 is also overexpressed reflecting its physiological role in optimizing energy distribution in a low-energy environment [20] . Cord serum concentrations of IGF-2 have been shown to have a significant positive effect on both birth length and weight, and cord serum IGFBP2 concentrations have been shown to correlate positively with weight gain during infancy [21, 22] . Site-specific increase in IGFBP1 phosphorylation may limit IGF-1 bioavailability, which in turn could contribute to the development of foetal growth restriction [23] ; and IGFBP1 protein in the placenta is negatively correlated with parameters of neonatal size [24] . There is also evidence that polymorphisms in the promoter region of IG-FBP3 are associated with IGFBP3 plasma levels in cord blood and in postnatal samples [25] .
The extent to which hepatic endocrine sensitivity can be programmed in utero and whether these adaptations persist into adulthood is largely unknown [26] . In addition, cytokines such as leptin may also play an important role in regulating placental formation and growth through interactions with the IGF-IGFBP axis. Relationships between cytokines and the IGF system have been shown in specific tissues [27] (for example, interleukin (IL)-6 and IGFBP2 mRNAs in the placenta have been shown to be significantly and positively correlated) [24] but little is known about these associations in the setting of developmental programming.
The present study examined changes in the circulating/ hepatic IGF-IGFBP axis in parallel models of maternal UN and maternal obesity to examine whether the common phenotype of obesity and metabolic syndrome is associated with a similar dysregulation of the IGF-IGFBP axis.
Materials and methods
The maternal high fat (HF) and UN models have been described by our group previously [1, 2, 28] . In brief, Wistar rats (age 100 ± 5 days) were time-mated using a rat oestrous cycle monitor to assess the stage of oestrous before introducing the male. After confirmation of mating, rats were housed individually in standard rat cages with free access to water. All rats were kept in the same room with a constant temperature maintained at 25°C and a 12-h light, 12-h dark cycle. Animals were assigned to one of three nutritional groups: (1) dams fed a commercially sourced standard diet (5 % fat, 18 % protein, digestible energy 3.4 kcal/g, Teklad Global Diet 2018) ad libitum throughout pregnancy and lactation (CONT group), (2) undernourished dams fed 50 % of a standard diet throughout pregnancy (UN group) and (3) dams fed a highfat diet throughout pregnancy and lactation (HF group; 24 % fat, 20 % protein; digestible energy 4.73 kcal/g, Research Diets Inc. D12451). A minimum of 8 l per maternal dietary group were used. Food intake was recorded daily until the end of pregnancy. After birth, pups were weighed and litter size was adjusted to eight pups per litter (four males and four females) on postnatal day 2 (P2) to ensure standardised nutrition until weaning at day 22. Plasma and livers were collected from unused male pups at P2. At weaning, all offspring were fed a commercial standard chow diet (Diet 2018) for the remainder of the study. Male offspring only were used for the present study to avoid the potential confounds of oestrus dynamics on the 
Quantitative polymerase chain reaction (qPCR) assays
For the quantification of hepatic gene expression levels and of the endogenous references rat hypoxanthine-guanine phosphoribosyltransferase (HPRT; mRNA RefSeq, NM_01 2583.2) and chloride channel nucleotide-sensitive 1A (CLNS1A; mRNA RefSeq, NM_031719.1), and beta-actin, a quantitative PCR assay was performed using the ABI PRISMH 7900HT Sequence Detection System (Applied Biosystems; Auckland, New Zealand). HPRT and CLNS1A primers were designed using Primer 3 software (version 0.4.0, Whitehead Institute for Biomedical Research) [30] ( Table 1 ) and manufactured by Invitrogen (Invitrogen Life Technologies; Auckland, New Zealand). Optimal primer conditions were adjusted to the following cycling conditions; Length: 20 bp (range 17-23 bp), Tm: 62°C (range 60-65°C) and amplicon length: 100-200 bp. Dissociation analyses were performed to ensure specificity and samples producing a single peak in the dissociation curves were used. Primer sequences were as follows: HPRT forward primer: TCCCAGCGTCGTGATTAGTG, HPRT reverse primer: CACACAGAGGGCCACAATGT; CLNS1A forward primer: AGTGGGGCAAAAGTGAGGTG, CLNS1A reverse primer: GATGGTAAATGAGGAGGAACAGAAG. Beta Actin and the remaining genes of interest (Hsp90, GHR, IGF-1, IGF-2, IGF-1R, IGF-2R, IGFBP1 and IGFBP2) were purchased from commercially available sources (Qiagen, Table 1 ). Quantification of gene expression levels were performed under the following conditions: an initial 2-min hold period at 50°C for normalisation (Stage 1), followed by enzyme activation at 95°C for 2 min (Stage 2); amplification of the gene product through 40 successive cycles of 95°C for 15 s then 60°C for 1 min (Stage 3); followed by a dissociation stage of 15 s at 95°C, 15 s at 60°C and 2 min at 99°C (Stage 4). A standard curve was generated from the mean cycle threshold (Ct) of eight standards (1:4 serial dilution) of a known concentration in triplicate, while amplification and dissociation curves were generated for all standards and samples (Applied Biosystems, California, USA). Each sample was run in triplicate. 
HSP heat-shock protein, GHR growth hormone receptor, IGF insulinlike growth factor, IGFBP insulin-like growth factor binding protein, R receptor subtype qPCR normalisation
Ct values for the constitutively expressed housekeeping genes beta-actin, HPRT and CLNS1A were used as normalisation factors for the gene of interest results. Normalisation genes must be chosen specifically for each set of experimental conditions with thorough statistical analyses performed to ensure that there are no discrepancies in normalised expression levels of housekeepers in response to experimental treatment [31] . As a next level of gene expression normalisation, the Quant-iT TM Oligreen Ò ssDNA Reagent and Kit was used (Molecular Probes, The Netherlands; cat. O1149) as an ultrasensitive fluorescent nucleic acid stain for quantifying oligonucleotides and single-stranded DNA (ssDNA) in solution. Samples were analysed in a 96-well microplate with a total reaction of 200 lL in each well. Each sample was run in triplicate with 5 lL cDNA sample, 95 lL TE and 100 lL of 1:200 diluted (in TE) Oligreen reagent in each well. After a 3-min incubation, fluorescence was read using a fluorescence microplate reader (Excitation/Emission 485/530 nm; BioTek Ò Synergy 2). Linearity was assessed by a cDNA standard curve. After background subtraction, fluorescence values were normalised in all samples and used in the calculation of overall geometric mean of the housekeeping genes.
DNA methylation DNA methylation of the IGFBP2 gene was undertaken at the Murdoch Childrens Research Institute (Melbourne, Australia). 500 ng of genomic DNA from each sample was bisulphite treated using MethylEasy Exceed kit (Human Genetics Signature, Sydney, Australia) to convert all unmethylated cytosines to uracils, which subsequently become thymines after PCR amplifications. DNA methylation levels of the Igfbp2 gene was measured using the Sequenom EpiTYPER MassArray platform (Sequenom, San Diego, USA) as previously described [32, 33] . Amplicons were designed using EpiDesigner software (http://www.epidesigner.com/) and MassArray R package [34] . Primer and target sequences, along with amplification cleavage product patterns and analysable CpG units are provided in Fig. 1 . The IGFBP2 assay was designed to flank upstream region of the transcription start site of the gene. PCR amplification conditions were as follow: 95°C for 10 min; 95°C for 10 s, 56-60°C for 30 s and 72°C for 1 min 30 s for 40 cycles; 72°C for 7 min. PCR amplifications and EpiTYPER reactions were performed in technical triplicates and mean methylation values were used in this analysis.
Plasma assays
Commercially available rat-specific kitsets were used for analysis of plasma insulin (CrystalChem, Downers Grove, USA Catalog #90060), leptin (CrystalChem, Catalog #90040), IGF-1 (Diagnostic Systems Laboratories, Inc.; Catalog # DSL-10-29200), IGFBP2 (Mediagnost, Reutlingen, Germany, Catalog# E08), IGFBP3 (Mediagnost, Cat E031) and IGFBP1 (USCN Life Science Inc, Catalog #E90052Ra). Lipid profiles were measured using an autoanalyser (Hitachi 902 Autoanalyser, Roche Diagnostics, IN, USA). IGF and IGFBP related measurements were limited to adult P160 samples due to insufficient plasma volume from P2 offspring. Blood glucose was assayed directly at the time of cull using a Roche Accu-Chek meter.
Statistical analysis
The effect of maternal nutrition on hepatic gene expression was measured using one-way analysis of variance (ANOVA) with maternal diet as a factor and where appropriate, post hoc analyses were performed (Holm-Sidak) to determine which dietary treatment groups were significantly different. Liver was used as a covariate with each litter representing a single biological replicate. Data that failed to meet the criteria required for parametric analysis (normal distribution and equal variance) were transformed where necessary. Data are presented as mean ± SEM unless otherwise stated and p values of less than 0.05 were considered statistically significant. All statistical analyses were performed using SigmaStat (Systat Software, San Jose, CA, USA).
Results

Maternal weights
Maternal UN resulted in a significant reduction in gestation weights until approximately day 15 (Fig. 2) . There was no significant difference in maternal weight gain between the CONT and HF dams (CONT 136 ± 5.3 g, HF 142 ± 6.1 g). By the end of lactation, maternal weights were similar across all dietary groups. Gestation length (monitored every 3 h during the daylight period) was increased by *24 h in the HF dams compared to CONT and UN groups (data not shown).
Offspring weights
Birth weights in male UN and HF offspring were reduced compared to CONT (CONT 6.3 ± 0.7 g, UN 5.0 ± 0.3, HF 5.5 ± 0.4, p \ 0.005 and p \ 0.01 for UN and HF versus CONT, respectively). Nose-anus length was significantly reduced at birth in UN and HF offspring compared to CONT and further reduced in UN compared to HF offspring (CONT 47.8 ± 0.3 mm, UN 44.5 ± 0.3, HF 46.1 ± 0.2, p \ 0.05 for UN and HF vs. CONT and p \ 0.05 for UN vs. HF). HF offspring showed catch-up growth and were not different in weight to CONT at weaning (Day 22); although UN offspring demonstrated catch-up growth they remained slightly but significantly (p \ 0.05) lighter than CONT animals (CONT 61.6 ± 0.7 g, UN 56.5 ± 1.04, HF 64.2 ± 1.2).
Adult body weights were significantly increased in HF offspring compared to CONT and were similar between CONT and UN groups (Males: CONT 562 ± 8 g, UN 594 ± 11, HF 628 ± 18, p \ 0.005 for maternal diet effect). Nose-anus length was significantly increased in HF offspring compared to CONT and UN groups (CONT 261.8 ± 1.4 mm, UN 260.8 ± 1.5, HF 268.7 ± 1.1, p \ 0.005 for maternal HF diet effect).
Body composition UN and HF adult male offspring had significantly increased total fat mass (%) compared to CONT offspring (Fig. 3) . Fat mass was further increased in HF offspring compared to UN offspring. Fat:lean ratios were significantly increased in UN and HF offspring compared to CONT and further increased in UN compared to HF offspring (CONT 0.32 ± 0.02, UN 0.55 ± 0.03, HF 0.81 ± 0.07, p \ 0.005). The absolute liver weights were increased in UN and HF offspring compared to CONT (CONT 16.2 ± 0.6 g, UN 18.3 ± 0.5, HF 18.1 ± 0.6, p \ 0.005). When corrected for percent body weight, relative liver weights remained higher in UN animals compared to other groups (CONT 2.85 ± 0.05 %, UN 3.16 ± 0.09, HF 2.83 ± 0.04, p \ 0.005).
Plasma analysis
P2 Offspring
UN and HF offspring were hypoinsulinemic and hypoleptinemic at birth compared to CONT offspring (Insulin: CONT 2.9 ± 0.6 ng/ml, UN 1.3 ± 0.3, HF 1.6 ± 0.2; Leptin: CONT 5.5 ± 1.6 ng/ml, UN 0.9 ± 0.2, HF 1.58 ± 0.3; p \ 0.05 for effect of maternal diet).
P160 Offspring
Plasma data for adult offspring are presented in Table 2 . IGF-1 levels were significantly reduced in UN and HF offspring compared to CONT but were not different between UN and HF offspring. IGFBP3 levels were significantly reduced in UN and HF offspring compared to CONT but were not different between UN and HF offspring. There were no significant differences between any of the groups in fasting plasma IGFBP1, IGFBP2 or glucose concentrations. Fasting leptin and insulin levels were significantly increased in UN and HF offspring compared to CONT. Plasma LDL, HDL and lipase levels were all significantly increased in UN and HF offspring compared to CONT.
Hepatic gene expression
P2 offspring
There were no significant differences in hepatic gene expression at P2 with the exception of a reduction in IG-FBP1 expression in HF offspring compared to CONT and UN groups (Table 3) .
P160 offspring
All data are presented in Table 4 and Fig. 4 . Hepatic IG-FBP2 and IGFBP1 mRNA levels were significantly reduced in UN and HF adult offspring compared to CONT. Hepatic heat-shock protein (HSP)90 mRNA levels were reduced in UN offspring compared to CONT and there was a trend towards a reduction in HF offspring (Table 4) . A strong correlation (R 2 = 0.75, p \ 0.005) was observed between hepatic HSP90 and IGFBP1 mRNA expression in CONT offspring which was absent in UN and HF offspring (R 2 = 0.12 and 0.04, respectively, Fig. 5 ). There was a significant increase in IGF-2R mRNA levels in HF offspring compared to CONT and UN offspring. There was no difference in hepatic mRNA levels of IGF-1, GHR, IGF-2 or IGF-1R between the treatment groups.
IGFBP2 methylation
There were no significant differences in any of the CpGs analysed for IGFBP2 methylation in P2 or P160 offspring livers across the three maternal dietary groups (Fig. 6) .
Discussion
This is the first study to our knowledge to examine potential changes in the IGF-IGFBP axis in adult rat offspring using disparate models of altered maternal nutrition to induce developmental programming. It has been well established that both relative maternal UN and HF nutrition elicit a phenotype in offspring characterised by increased adiposity and altered insulin and leptin sensitivity [35] [36] [37] . In the present study, maternal UN and HF diets resulted in increased adiposity in male offspring concomitant with fasting hyperinsulinemia, hyperleptinemia and alterations in lipid profiles. We have now shown that these offspring also have reductions in circulating IGF-1 and IGFBP3 levels and significant reductions in hepatic IGFBP1 and IGFBP2 mRNA expression levels. Interestingly, the reductions in hepatic IGFBP1 and -2 mRNA expression were not paralleled by any significant changes in circulating plasma IGFBP1-2 or IGFBP2 methylation. Further, the reductions in plasma IGF-1 and IGFBP3 in programmed offspring were independent of changes in body weight/ length and may, therefore, reflect hepatic insulin resistance, fatty liver disease or an altered body composition via increased fat:lean ratios. Both UN and HF offspring had reduced birthweights. Maternal obesity, although often associated with large offspring birthweight and macrosomia, is also characterised by foetal growth restriction, possibly due to placental insufficiency as reported by our group and others [38, 39] . Of note, despite reduced birthweights and neonatal hypoleptinemia and hypoinsulinemia in UN and HF offspring, there were no marked differences in neonatal hepatic gene expression compared to controls.
We and others have shown that both maternal UN and maternal obesity are associated with reduced circulating IGF-1 levels in offspring at birth [40, 41] . Findings from genetic and nutrition studies suggest that foetal plasma IGF-1, potentially from a non-hepatic source, correlates with foetal growth and that aberrant hepatic IGF-1 expression may be programmed during the foetal period but may not result in an abnormal phenotype until later adult life. In addition, we observed increased plasma cholesterol (LDL, HDL and total cholesterol) and lipase levels in UN and HF offspring compared to controls-elevations in cholesterol levels commonly parallel increased adiposity and hyperinsulinemia as shown in the current study.
Our observed reductions in IGFBP2 expression in both UN and HF offspring is in agreement with previous studies in mice where a high body weight gain was reflected by reduced hepatic IGFBP2 mRNA levels compared to control mice [42] . IGFBP2 plays a central role in the insulin-IGF system cross-talk and is closely linked to insulin resistance, thereby providing a further explanation for its association with the metabolic syndrome [43] . IGFBP2 has been reported to have marked anti-diabetic effects that are regulated in part by leptin [12] and several studies have shown that IGFBP2 overexpression can reverse diabetes in insulin-resistant ob/ob, Ay/a, and diet-induced obese mice, as well as insulin-deficient streptozotocin-treated mice [12] . Moreover, hyperinsulinemic clamp studies showed a threefold improvement in hepatic insulin sensitivity following IGFBP2 treatment of ob/ob mice [12] . Our data now suggest that the opposite also holds true demonstrating that reduced IGFBP2 mRNA expression is paralleled by impaired insulin sensitivity and increased adiposity in our model. These changes in IGFBP2 mRNA expression were independent of any significant difference in plasma IG-FBP2 levels across the maternal dietary groups.
DNA methylation at CpG sites is an important component of epigenetic gene expression regulation, resulting in modulation of protein-DNA interactions [44] . The promoter region of the IGFBP2 gene is rich in CpGs and lacks a TATA box and is highly conserved in mammalian species [45] . It is, therefore, plausible that methylation plays an important role in regulating the expression of this gene. However, despite marked reductions in hepatic IGFBP2 mRNA expression, we observed no significant differences in IGFBP2 DNA methylation, with a generalised hypomethylation of the IGFBP2 promoter across all offspring groups. IGFBP2 hypomethylation has been reported in other model species including the zebrafish [44] . Little is known about the role of IGFBP2 methylation as relates to the metabolic syndrome although aberrant IGFBP2 methylation has been studied widely as relates to carcinomas, particularly hypermethylation in hepatic and lung cancer [46, 47] . Our findings of differential expression in the absence of altered DNA methylation suggest an alternative epigenetic mechanism for regulation of the IGFBP2 gene in our rat model.
We observed reduced plasma IGF-1 levels concomitant with hyperleptinemia. The physiological relationship between leptin and IGF-1 is poorly understood. Fontan et al. [48] suggested that leptin could primarily regulate IGF-1 secretion and overexpression of leptin in transgenic mice results in a reduction in circulating IGF-1 levels [49] . However, it has also been shown that GH and IGF-1 can modify serum leptin levels, albeit in patients with latestage renal disease [50] . In the setting of malnutrition, IGF-1 levels tend towards a decrease, while leptin levels are increased [51] . Of note, it has been reported that hyperleptinemia, low plasma IGF-1 or IGFBP3, and insulin resistance may contribute to the pathogenesis of preeclampsia and related foetal growth restriction [52] .
Insulin acutely decreases IGF-1 bioactivity through differential modulation of IGFBPs [53] . Plasma IGFBP1 levels are normally inversely regulated by insulin and glucose [54] . However, we observed no changes in fasting plasma IGFBP1 across any of the treatment groups despite marked hyperinsulinemia in UN and HF offspring with no significant correlation between plasma insulin and plasma IGFBP1. A lack of an inverse relationship between insulin and IGFBP1 has been reported by others [55] and may relate in part to the dynamic regulation of IGFBP1 in the circulation. However, we observed marked reductions in hepatic IGFBP1 mRNA expression in UN and HF adult offspring. Hepatic production of IGFBP1 is under direct inhibitory influence of insulin and increased insulin secretion results in suppression of hepatic IGFBP1 secretion. This is in agreement with our observations of hyperinsulinemia coupled with markedly reduced hepatic IGFBP1 mRNA expression. We report a significant positive association between hepatic HSP90 and IGFBP1 expression that was absent in UN and HF groups. HSP90 is a molecular chaperone that assists the folding or unfolding and the assembly or disassembly of other proteins and plays a well-established role in signalling protein function, trafficking and turnover [56] . Inhibition of HSP90 has been shown to induce cellular stress and pro-apoptotic pathways [57] . As such it has been proposed that stable cycling of HSP90 may serve to buffer against protein damage and, therefore, decreased HSP90 expression would likely lead to diminished protein functionality [56] . There are few in vivo data on the interaction between HSP90 and the other IGF-IGFBP gene targets apart from limited reports in the cancer literature or performed in vitro [58, 59] . IGFBP2 synthesis is governed by IGF receptor ? phosphatidylinositol 3-kinase ? Akt pathway, which is supervised by HSP90 and HSP90 inhibitors that can dose-dependently decrease secretion of IGFBP2 in vitro [60] . HSP90-dependent degradation of targets upstream of IGFBP2 has, therefore, been proposed to result in downregulation of IGFBP2 in serum [60] . Blocking HSP90 may also disrupt IGF-1-and IL-6-induced signalling cascades by targeting IGF-1R and STAT3, leading to significant growth-inhibitory effects [61] . It has also been shown that HSP90 interacting with IRS-2 is involved in cAMP-dependent potentiation of IGF-1 signals in vitro [59] .
One potential mechanism of IGFBP action is via altered cell-cycle dynamics. An appropriate level of IGFBP1 expression is critical for proper control of the hepatocyte cell cycle [62] . We have previously reported that offspring of mothers fed a HF diet display hepatic cell-cycle inhibition and associated changes in Cdkn1a (p21, cell-cycle inhibitor) gene expression and DNA methylation [63] . Although cell-cycle dynamics were not tested directly in this study, our previous observations of aberrant cell-cycle regulation coupled with the present observation of reduced hepatic IGFBP1 expression at P2 point towards a possible mechanism for long-term liver dysfunction. However, this would not account for the changes observed in UN adult offspring where although similar dysregulation of cellcycle control has been reported in a model of maternal UN [64] , we observed no significant changes in IGFBP1 expression in P2 livers.
Work by Zhang et al. [65] has recently shown that a maternal HF diet during pregnancy and lactation altered hepatic expression of IGF-2 in adult offspring. We observed no differences in hepatic IGF-2 mRNA expression in nutritionally challenged offspring at any time. These inconsistencies could relate to sex-or species-specific differences in the studies; the Zhang study utilised female mice whereas we examined male offspring to remove the potential confounds of oestrous phases. Further, and in contrast to our study, in female mice offspring there was no effect of the maternal HF diet on postnatal growth and lipid profiles. We observed no changes in hepatic IGF-1 mRNA expression at birth in either UN or HF offspring, despite a reduction in birth weight compared to controls. Reduced hepatic IGF-1 mRNA expression has been reported in the late gestation foetus in the uterine ligation model [66] and these differences from the present study may simply reflect the nature of the insult or timing of sample collection (late gestation versus neonatal). Limited sample volume precluded us from assessing circulating IGF-1 levels in neonates in the present study but we have previously reported reduced IGF-1 levels at birth in a maternal UN model of growth restriction [67] . Circulating plasma IGF-1 levels were reduced in UN and HF adults compared to controls; this may be reflective of increased adiposity in these groups and the consequence of GHresistance associated with obesity.
Both maternal UN and nutritional excess resulted in obesity and metabolic dysregulation in adulthood. These data closely mimic data from clinical studies and epidemiological cohorts where both maternal under-and overnutrition result in metabolic disorders in offspring [35, 36, [68] [69] [70] . Although a significant increase in the absolute body weight was observed only for HF offspring compared to controls, the increased adiposity observed in UN and HF offspring was paralleled by a significant increase in fat:lean ratios. This common phenotype was also characterised by marked suppression in hepatic IGFBP mRNA expression levels and is paralleled by decreased circulating levels of IGF-1 and IGFBP3. This dysregulation, particularly for IGFBPs 1 and 2, may be mediated in part by alterations in the molecular chaperone HSP90. Given the recent data on the beneficial consequences of IGFBP2 overexpression and reversal of metabolic dysfunction, the present data show that the reverse holds true with reduced expression of IG-FBP2 associated with increased adiposity and impaired insulin sensitivity. Previous work on IGFBP1 is less clear; overexpression of IGFBP1 has been shown to result in inhibition of IGF action and in profound impairment of brain development, modest inhibition of foetal and postnatal growth, and inhibition of the metabolic effects of the IGFs [71] . The observed lack of a relationship between hepatic mRNA expression for IGFBPs 1-2 and circulating plasma levels may be a consequence of other tissues contributing to the circulating IGFBP pool. For example, IG-FBP2 is an adipokine secreted by white adipocytes and its regulation is known to be altered in an adipose depotspecific manner in diet-induced obesity and insulin resistance [72] . Furthermore, both maternal under-and overnutrition are known to be associated with non-alcoholic fatty liver disease in offspring [73] [74] [75] . Circulating IGF-1 levels were reduced in UN and HF offspring compared to controls. NAFLD is known to lead to a reduction in IGF-1 and IGFBP3 with hepatic insulin resistance affecting IGF-1 levels by modulating GH-stimulated synthesis of hepatic IGF-1 [76, 77] . Thus hepatic lipid accumulation as shown by us and others in these models of altered maternal nutrition may represent one mechanism underpinning the aberrant IGF-IGFBP axis.
Although not examined in the present study, animal studies suggest that dysregulation of IGFBP4 is significant in the development of IUGR, although human data are lacking. It has been suggested that IGFBP4 is expressed at the maternal foetal interface and plays a role in regulating IGF bioavailability. Thus, maternal serum levels of IG-FBP4 may be associated with complications of abnormal placental growth and development including IUGR [78] . In addition, obesity is characterised by a chronic state of lowgrade inflammation and inflammation is an important modulator of the IGF/IGFBP system leading to an overall reduction in IGF bioavailability [79] . Work by Street et al. [79, 80] showed that increases in serum concentrations of inflammatory markers in the setting of inflammatory disease were paralleled by a reduction in serum concentrations of IGF-1 and IGF-2 and a significant increase in insulin levels. Future work will examine the relationship between the IGF-IGFBP system and inflammatory profiles and their association with growth patterns. We have recently published reincreased inflammatory markers in offspring following either maternal UN or maternal obesity [81] [82] [83] . We would, therefore, expect the relationship between active inflammation and modification of the IGF-IGFBP system as reported by Street et al. to hold true in the setting of developmentally programmed obesity and metabolic disorders.
In summary, both maternal UN and overnutrition result in obesity in adult offspring concomitant with hyperinsulinemia and hyperleptinemia. The present observations are the first to show dysregulation of a common pathway underpinning a compromised metabolic and obesogenic phenotype utilising two disparate models of altered maternal nutrition. Importantly, the data derived from our animal model closely parallel that reported in the human literature for offspring born SGA including reduced circulating plasma IGF-1 and IGFBP3 levels [84] [85] [86] [87] and hyperinsulinemia and hyperleptinemia in early life following catch-up growth [88, 89] . However, direct comparisons in many cases are difficult due to clinical intervention strategies such as GH treatment which directly impact on insulin sensitivity and components of the IGF-IGFBP axis. Further, in the present study we cannot conclude that the mechanisms leading to the dysregulation of the pathways are the same, rather the resultant changes in the IGF-IGFBP axis manifest via either under-or overnutrition are similar. However, importantly, these data further reinforce a role for IGFBP2 as a possible intervention target to ameliorate the consequences of early life nutritional compromise.
